首页> 外国专利> RECOMBINANT OF VV-GMCSF / LACT-DGF VIRUS OF OSVOVICINE, OF ONLY-COLIC ACTIVITY AND PRODUCING SECRETABLE CHIMERIC WHITE, CONTAINING FROM GRANULOCYTE-MACROPHAGAL COLONISTIMULATING HUMAN FACTOR AND ONCOTOXIC PROTEIN OF LACTAPTIN

RECOMBINANT OF VV-GMCSF / LACT-DGF VIRUS OF OSVOVICINE, OF ONLY-COLIC ACTIVITY AND PRODUCING SECRETABLE CHIMERIC WHITE, CONTAINING FROM GRANULOCYTE-MACROPHAGAL COLONISTIMULATING HUMAN FACTOR AND ONCOTOXIC PROTEIN OF LACTAPTIN

机译:重组由卵泡-巨噬细胞集落刺激人因子和乳糖的毒素组成的VV-GMCSF /乳腺病毒的LACT-DGF病毒的重组体,仅具有结肠活性并产生可分泌的嵌合白色

摘要

FIELD: biotechnology.;SUBSTANCE: recombinant strain has targeted oncolytic activity and produces a secreted chimeric protein consisting of human GM-CSF and lactaptin (GMCSF/lact). The strain VV-GMCSF/lact-dGF is constructed on the basis of the L-IVP strain of the vaccinia virus, which contains deletions of fragments of viral thymidine kinase and growth factor genes. The transgene of the chimeric protein GMCSF/lact is incorporated into the deletion region of the thymidine kinase gene, which includes the GM-CSF gene adjuvant, which is linked through a flexible GlyGlyGlySer linker to the oncotoxic peptide lactaptin. The claimed strain has a virulence decreased by more than 100-fold as compared to the initial L-IVP strain, as well as a high targeted oncolytic activity against human tumor cells of various genesis. The strain was deposited in the State Collection of the causative agents of viral infections and rickettsiosis of the SSC VB Vector under the registration number V-711 (18.04.2016).;EFFECT: invention provides additional attenuation of the VACV virus against normal cells and enhances its lytic activity against cancer cells, and can also be used in biotechnology.;8 dwg, 3 tbl, 6 ex
机译:领域:生物技术;目的:重组菌株具有针对性的溶瘤活性,并产生由人GM-CSF和乳蛋白酶组成的分泌型嵌合蛋白(GMCSF /乳杆菌)。 VV-GMCSF / lact-dGF菌株是在牛痘病毒的L-IVP菌株的基础上构建的,该菌株含有病毒胸苷激酶和生长因子基因片段的缺失。嵌合蛋白GMCSF / lact的转基因被掺入胸腺嘧啶激酶基因的缺失区域,该区域包括GM-CSF基因佐剂,该佐剂通过柔性GlyGlyGlySer接头与致癌肽乳蛋白酶结合。与最初的L-IVP菌株相比,所要求保护的菌株的毒力降低了100倍以上,并且针对各种起源的人肿瘤细胞具有高靶向的溶瘤活性。该菌株以注册号V-711(18.04.2016)保藏在SSC VB载体的病毒感染和立克次病病原体的州立档案馆中;效果:本发明提供了VACV病毒针对正常细胞的进一步减毒作用增强其对癌细胞的裂解活性,也可用于生物技术。; 8 dwg,3 tbl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号